why choose us

Clinical Trials Search

Showing 8,230 of 132,656 result(s)
A Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of UCB0022 in Study Participants With Advanced Parkinson's Disease

Status: COMPLETED

Condition: Parkinson Disease

Interventions: Study participants will receive placebo orally administered as tablet at pre-specified time points during the study.

Date: 2023-09-20

A Study Evaluating Safety, Tolerability, and Clinical Activity of Forimtamig-Based Treatment Combinations in Participants With Relapsed or Refractory Multiple Myeloma

Status: COMPLETED

Condition: Relapsed or Refractory Multiple Myeloma

Interventions: Forimtamig will be administered SC at different doses during dose exploration phase.
Forimtamig will be administered at a fixed dose determined d

Date: 2023-09-20

Opportunistic Fragility Fracture Risk Estimates From Radiographs

Status: COMPLETED

Condition: Osteoporosis

Interventions: A software application applied to radiographs

Date: 2023-09-20

A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM)

Status: Completed

Condition: Multiple Myeloma, Smoldering

Interventions: For 2 weeks, patients will receive omega 3 fatty acid supplements 1640 mg (2 capsules) twice daily

Date: 2023-09-20

19F MRI in Healthy Children and Children With Mild Cystic Fibrosis Lung Disease

Status: NOT_YET_RECRUITING

Condition: Cystic Fibrosis in Children

Interventions: Inhalation of a biologically inert contrast gas, perfluoropropane, combined with 19F-tuned MRI with image acquisition at breath-hold and during tidal

Date: 2023-09-20

A Study of HB0045 Injection in Patients With Advanced Solid Tumors

Status: Completed

Condition: Solid Tumor, Adult

Interventions: Patients will be assigned to dose regimens in the order of enrollment and receive their assigned fixed dose of HB0045 via intravenous infusion, Q3W.

Date: 2023-09-20

A Proof of Concept Study to Evaluate Exosomes From Human Mesenchymal Stem Cells in Women With Premature Ovarian Insufficiency (POI)

Status: Completed

Condition: Premature Ovarian Insufficiency

Interventions: VL-PX10 is a decellularized product consisting of proteins, lipids, and nucleic acids derived from human placenta mesenchymal stem cells.

Date: 2023-09-20

Testing the Effectiveness of Night Shift, a Theory-based Customized Video Game

Status: Completed

Condition: Trauma Injury

Interventions: The player must not only manage the patients who present to the emergency department of the hospital, gaining experience with the consequences of trau

Date: 2023-09-20

Triple Immune Checkpoint Inhibition for Advanced or Metastatic PD-(L)1 Refractory Merkel Cell Carcinoma

Status: Completed

Condition: Unresectable Clinical Stage III Merkel Cell Carcinoma AJCC v8

Interventions: Undergo tumor biopsy

Date: 2023-09-20

Unified Protocol for Preventing Emotional and Academic Challenges in Education (U-PEACE)

Status: Completed

Condition: Emotions

Interventions:

This program will involve about 13 group sessions, with each group session lasting approximately 40-50 minutes.
The program session will be he

Date: 2023-09-20